Jade Biosciences, Inc. · NASDAQ:JBIO
Janus Henderson Group PLC reported a 10.60% stake in Jade Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
Janus Henderson Group PLC reported a 10.60% stake in Jade Biosciences, Inc., 6,273,262 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 10.60%
- Shares
- 6,273,262
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP Ltd. | 10.60% | 6,273,262 |
Source
Related
- Jade Biosciences, Inc.
- Janus Henderson Group PLC
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026